Begin main content

Reports

We found 5097 result(s)

lumacaftor/ivacaftor (Orkambi )

Last Updated: June 14, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: lumacaftor/ivacaftor
Indications: Cystic Fibrosis, F508del CFTR mutation in patients 6 years and older

  • Brand Name: Orkambi
  • Manufacturer: Vertex Pharmaceuticals (Canada) Incorporated
  • Project Number: SR0559-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Cystic Fibrosis, Cystic Fibrosis, Respiratory

benralizumab (Fasenra)

Last Updated: June 14, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: benralizumab
Indications: Asthma, severe eosinophilic

  • Brand Name: Fasenra
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0561-000
  • Project Status: Active
  • Submission Type: New

Tags

Asthma, Asthma, Respiratory

letermovir (Prevymis)

Last Updated: June 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: letermovir
Indications: Cytomegalovirus infection, prophylaxis

  • Brand Name: Prevymis
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0545-000
  • Project Status: Active
  • Submission Type: New

Tags

Infectious Diseases, Cystinosis, Delayed-Action Preparations, HIV/AIDS, Infectious diseases, cysteamine bitartrate; Procysbi; nephropathic; cystinosis; extended release; delayed action; delayed release; controlled release; Long acting; time release

crisaborole (Eucrisa)

Last Updated: June 13, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: crisaborole
Indications: atopic dermatitis

  • Brand Name: Eucrisa
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0570-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Dermatology

sucroferric oxyhydroxide (Velphoro )

Last Updated: June 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: sucroferric oxyhydroxide
Indications: Hyperphosphatemia, end-stage renal disease

  • Brand Name: Velphoro
  • Manufacturer: Vifor Fresenius Medical Care Renal Pharma
  • Project Number: SR0571-000
  • Project Status: Received
  • Submission Type: New

Tags

Kidney

e-Therapy Interventions for the Treatment of Post-Traumatic Stress Disorder: Clinical Evidence

Published on: June 13, 2018
Result type: Reports
Product Line: Rapid Response
Research Type: Devices and Systems

  • Project Number: RC0985-000

Tags

Mental Health, Telehealth, Internet, Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Telemedicine, Mental health, Telehealth, PTSD, Posttraumatic stress, posttraumatic stress disorder, posttraumatic stress disorders, post traumatic stress, Panic, combat disorder, shell shock, panic attack, panic disorder

nitisinone (Nitisinone )

Last Updated: June 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nitisinone
Indications: Hereditary tyrosinemia type 1

  • Brand Name: Nitisinone
  • Manufacturer: Cycle Pharmaceuticals Ltd.
  • Project Number: SR0554-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Pediatrics, Genetics, Pediatrics

eluxadoline (Viberzi)

Last Updated: June 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: eluxadoline
Indications: Irritable bowel syndrome with diarrhea

  • Brand Name: Viberzi
  • Manufacturer: Allergan Pharma Co.
  • Project Number: SR0560-000
  • Project Status: Active
  • Submission Type: New

Tags

Digestive System, Gastrointestinal Tract, Diarrhea, Irritable Bowel Syndrome, Digestive system, Gastrointestinal tract, irritable bowel; Diarrhea

bictegravir/emtricitabine/tenofovir alafenamide (TBC)

Last Updated: June 11, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: bictegravir/emtricitabine/tenofovir alafenamide
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: Gilead Sciences Canada, Inc.
  • Project Number: SR0567-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV/AIDS, Infectious diseases